Search for: "Boehringer Ingelheim, Inc."
Results 1 - 20
of 155
Sort by Relevance
|
Sort by Date
6 May 2024, 8:26 am
” Warning letters were sent to 10 manufacturers, including, among others, Teva (identifying 58 listings), Novo Nordisk (36 listings), and Boehringer Ingelheim (10 listings). [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
13 Nov 2023, 4:10 pm
Boehringer Ingelheim Pharmaceuticals, Inc., Williams asks the court to grant review and reverse the 11th Circuit’s ruling. [read post]
12 Apr 2023, 4:00 am
Sandoz Canada Inc., 2023 FC 243 at para 29. [6] See Boehringer Ingelheim (Canada) Ltd. v. [read post]
21 Apr 2021, 4:00 am
It is well established in trademark jurisprudence that the owner of a mark is not legally responsible for torts allegedly perpetrated by its user: Batten v Boehringer Ingelheim (Canada) Ltd., 2017 ONSC 53, at para. 153. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 Sep 2020, 6:56 am
Boehringer Ingelheim Pharms., Inc., 2020 WL 5258317, No. 19-5321 (E.D. [read post]
5 Apr 2020, 9:57 pm
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
13 Nov 2019, 9:15 am
In Celltrion, Inc. v. [read post]
11 Nov 2019, 3:21 am
In re Boehringer Ingelheim Vetmedica, Inc., Serial No. 87072333 (November 6, 2019) [not precedential] (Opinion by Judge David Mermelstein).During examination, the USPTO must analyze the specimens of use to determine whether the purported mark would be perceived as a source indicator. [read post]
1 Aug 2019, 8:30 am
Boehringer Ingelheim Corp., et al., a $150 million settlement with GlaxoSmithKline PLC, and a $190 million settlement with Aventis Pharmaceuticals, Inc. [read post]
21 Jul 2019, 7:55 pm
Casino Rama Services Inc. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
